Core Prescribing Solutions noted that the MHRA has updated its protocols for parenteral nutrition administration after reports of adverse incidents, including a fatal embolism.
Public source
Publisher name
Public post
This Week in Primary Care 🔔 Your essential Tuesday briefing - 4 updates, 2 minutes. • Immunisation: Nearly 250,000 young people have received a MenB vaccine since th…
Company
Core Prescribing Solutions
"Your Professional & Trusted Partner"
- Industry
- Medical Practices
- Location
- Bradford, GB
- Company size
- 51–200 employees
About Core Prescribing Solutions
Core Prescribing Solutions is an award-winning healthcare organisation with more than 25 years of combined experience across the NHS, primary care, clinical pharmacy and health informatics. We work closely with GP practices, PCNs and wider NHS partners to reduce workload pressures, strengthen prescribing safety and improve patient outcomes. Our team delivers fully managed clinical pharmacist and pharmacy technician support that fits the needs of each practice. This includes structured medication reviews, medicines optimisation, long-term condition management, repeat prescription processing, acute workflow support and clinical audits. We also help practices prepare for CQC inspections, improve governance, and streamline day-to-day systems so teams can focus on patient care. We use real-world data and practical insights to create smarter ways of working. Whether it’s redesigning prescription flow, supporting ARRS workforce management, or improving digital processes, our aim is simple: better outcomes for patients, better efficiency for practices and long-term value for the NHS.
See moreLatest activity
Latest activity from Core Prescribing Solutions
9 signals
Research & Knowledge
Core Prescribing Solutions reported that nearly 250,000 young people have received a MenB vaccine since the catch-up campaign began in July, requiring two doses for full protection.
Research & Knowledge
Core Prescribing Solutions noted that NICE has updated its psychosis and schizophrenia guideline, clarifying antipsychotic medication terminology.
Operations & Supply
Core Prescribing Solutions highlighted that active Serious Shortage Protocols remain in place for Creon, Estradot patches, and Ramipril 1.25mg capsules.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
Crest Medical Ltd
Crest Medical Ltd updated its workplace first aid kit standards to align with the 2026 amendments, providing clearer guidance on AEDs and industry-specific first aid kits.
Legal & Regulatory
Independent Doctors Federation
Independent Doctors Federation noted that in July 2026, NICE recommended EndoSure for use in the NHS
Legal & Regulatory
PHP Aesthetic-PHP Wellness
PHP Aesthetic-PHP Wellness notes that in February 2025 the FDA removed the boxed cardiovascular warning from testosterone products while adding a new warning about raised blood pressure.
Legal & Regulatory
ASHP
ASHP and its members raised concerns to the FDA after the sole 503B supplier of the products decided to exit the market, with the FDA announcing steps to maintain newborn access to parenteral nutrition products including temporary compounding flexibilities.
Legal & Regulatory
Fusion Pharma Limited